Home
Challenges and Opportunities for Effective Cancer Immunotherapies
Barnes and Noble
Challenges and Opportunities for Effective Cancer Immunotherapies
Current price: $136.25
![Challenges and Opportunities for Effective Cancer Immunotherapies](https://prodimage.images-bn.com/pimages/9783036569604_p0_v1_s600x595.jpg)
![Challenges and Opportunities for Effective Cancer Immunotherapies](https://prodimage.images-bn.com/pimages/9783036569604_p0_v1_s600x595.jpg)
Barnes and Noble
Challenges and Opportunities for Effective Cancer Immunotherapies
Current price: $136.25
Size: OS
Loading Inventory...
*Product information may vary - to confirm product availability, pricing, shipping and return information please contact Barnes and Noble
Anti-cancer immunotherapies have generated spectacular outcomes in the clinical environment and changed treatment schemes for cancer patients. Adoptive cell therapies (ACTs), including using autologous tumor-infiltrating lymphocytes and chimeric antigen receptor (CAR) T cells, and checkpoint blockades have emerged as the most effective treatments for certain cancers. The current challenge for cancer immunotherapies is that although some patients have benefited from the treatments, a number of cancers are resistant. The purpose of this Special Issue is to understand anti-cancer immunotherapy treatment resistance mechanisms and explore new options to provide opportunities for effective treatments.